We Are Samaras

Harnessing the power of site intelligence to accelerate clinical trials

Founder Message

Samaras started with a quiet urgency—and a sense of responsibility.

After more than two decades working alongside site teams and operators, one truth is clear: the greatest challenge in clinical trials isn’t science—it’s fragmented systems and time lost to unnecessary complexity. Talented teams are forced to manage process instead of focusing on patients and progress.

Samaras exists to give that time back. By creating a connective-orchestrated intelligence layer across the clinical lifecycle, we help teams work with clarity, rigor, and continuity—without adding noise.Because every delay has a human cost, and operational excellence in trials isn’t optional. It’s a responsibility.
‍
Kaye Doiron | CEO-Founder

Innovation Summit Keynote

Why Samaras Exists?

A message from Kaye
‍

Founder Vision

Click Here to see our Founders message

01

Beautiful hills & stuff

02

Some kind of cave

Ehm, a cool house

03

Socratic Teaching

Adaptive Learning

Real-Time Feedback

Competency Mapping

Socratic Teaching

Adaptive Learning

Real-Time Feedback

Competency Mapping

Socratic Teaching

Adaptive Learning

Real-Time Feedback

Competency Mapping

Site_Enablement

Site_Training

Simulations

Patient_Education

Patient_Recruitment

Patient_Engagement

Protocol_Intelligence

Clinical_Reasoning

Pharmacovigilance

Process_Mapping

KPI_Tracking

Clinical_Reasoning

Pharmacovigilance

Safety

Site_Enablement

Simulations

Samaras

is an agentic orchestration layer that connects fragmented clinical trial systems and applies contextual clinical and protocol intelligence across end-to-end trial workflows, informed by over 20 years of operational data.

Get Started

Learn more about Samaras

Stay Connected

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Learn more about Samaras

Stay Connected

A Thinkhat Venture Studio Company
KeynoteComplaint dept
Stay tuned for more updates

Samaras is building the system that changes it.

Three pillars that turn any site into a trial-ready operation.

Regardless of experience level, team size, or portfolio complexity — Samaras builds the training infrastructure that lets sites do more with the teams they have, and rapidly upskill the ones they're bringing in.

Watch — Innovation Network

Patient Negative One

Founder Kaye Doiron at the Innovation Network Gathering — on why clinical trials fail patients before they ever begin, and the insight that sparked Samaras.

Watch the talk
01
SITE ENABLEMENT
Scale and upskill the workforce — fast.
Samaras delivers simulation-based training thatadapts to each learner — building proficiency through agentic, interactive case studies with real-time mastery feedback. We help medical professionals offer clinical trials as a care option, not a specialty reserved for the already experienced.
02
PROTOCOL SPECIFIC TRAINING
Trial-ready teams before day one.
Powered by PIA's deep protocol intelligence, Samaras generates protocol-specific training environments where teams demonstrate proficiency before a trial begins. We build workflow process maps and keep sites aligned from activation through close-out.
03
PATIENT EDUCATION
Standardize and automate the patient experience.
Samaras standardizes and automates protocol-specific patient education — ensuring every patientreceives consistent, accurate information about thetrial they're entering, in language they can understand, at every site.
01
INTAKE
Capture patients protocol-agnostically
MIA, our Medical Intake Agent, is clinically grounded and collects a comprehensive medical history curated for clinical trials, creating space for each patient interested in clinical trial
participation.
02
INTELLIGENCE
Match across all protocols simultaneously
The Protocol Intelligence Agent (PIA) evaluates each patient against your entire active portfolio — finding matches human screeners lack the time to catch.
03
THE FUTURE
From finding patients for trials — to building trials for patients.
The longitudinal patient data captured by MIA doesn't just solve today's recruitment problem. It becomes the foundation for a fundamental industry shift — where sponsors design protocols around patient populations that actually exist, not the other way around.